The projection is based on the expectation that the drug-maker will have enough data to seek an Emergency Use Authorization [EUA] from the Food and Drug Administration by the end of the month.
Source: NY Post click here for more…
The projection is based on the expectation that the drug-maker will have enough data to seek an Emergency Use Authorization [EUA] from the Food and Drug Administration by the end of the month.
Source: NY Post click here for more…